Diagnosing Dementia in the Clinical Setting: Can Amyloid PET Provide Additional Value Over Cerebrospinal Fluid?

Canadian Consensus Guidelines on Use of Amyloid Imaging in Canada: Update and Future Directions from the Specialized Task Force on Amyloid imaging in Canada

(2016) Robert Laforce et al.   CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES

Florbetapir positron emission tomography and cerebrospinal fluid biomarkers

(2015) Ann Hake et al.   Alzheimers & Dementia

Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage

(2015) Stephanie J. B. Vos et al.   BRAIN

Dissecting IWG-2 typical and atypical Alzheimer’s disease: insights from cerebrospinal fluid analysis

(2015) Ross W. Paterson et al.   JOURNAL OF NEUROLOGY

Amyloid biomarkers in Alzheimer's disease

(2015) Kaj Blennow et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Asymmetry and heterogeneity of Alzheimer’s and frontotemporal pathology in primary progressive aphasia

(2014) M.-Marsel Mesulam et al.   BRAIN

Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association

(2013) Keith A. Johnson et al.   Alzheimers & Dementia

Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging

(2013) Keith A. Johnson et al.   Alzheimers & Dementia

Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloid

(2013) Susan M. Landau et al.   ANNALS OF NEUROLOGY

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study

(2013) Victor L Villemagne et al.   LANCET NEUROLOGY

Practical utility of amyloid and FDG-PET in an academic dementia center

(2013) P. Sanchez-Juan et al.   NEUROLOGY

Classification and pathology of primary progressive aphasia

(2013) J. M. Harris et al.   NEUROLOGY

Potential Impact of Amyloid Imaging on Diagnosis and Intended Management in Patients With Progressive Cognitive Decline

(2012) Michael Grundman et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Impact of molecular imaging on the diagnostic process in a memory clinic

(2012) Rik Ossenkoppele et al.   Alzheimers & Dementia

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

(2011) Christopher M. Clark   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Classification of primary progressive aphasia and its variants

(2011) M. L. Gorno-Tempini et al.   NEUROLOGY

Primary progressive aphasia: clinicopathological correlations

(2010) Murray Grossman   Nature Reviews Neurology